Maintenance therapy in multiple myeloma. - Suppr | 超能文献

Maintenance therapy in multiple myeloma.

作者信息

Kumar Shaji

机构信息

Mayo Clinic, Rochester, Minnesota.

出版信息

Clin Adv Hematol Oncol. 2014 Feb;12(2):133-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Maintenance therapy in multiple myeloma.

Clin Adv Hematol Oncol. 2014 Feb;12(2):133-4.

2

Counterpoints: Do patients with multiple myeloma need maintenance treatment? No, maintenance treatment should not be used outside clinical trials.

Clin Adv Hematol Oncol. 2015 Mar;13(3):163, 167-9.

3

Counterpoints: Do patients with multiple myeloma need maintenance treatment? Yes, but the proper candidates and schedule must be determined.

Clin Adv Hematol Oncol. 2015 Mar;13(3):163-6.

4

Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of "progression-free survival 2" as a clinical trial end-point.

Haematologica. 2015 Aug;100(8):e328-30. doi: 10.3324/haematol.2014.120790. Epub 2015 Apr 3.

5

Multiple myeloma: Current advances and future directions.

Best Pract Res Clin Haematol. 2020 Mar;33(1):101155. doi: 10.1016/j.beha.2020.101155. Epub 2020 Feb 5.

6

Optimising bortezomib in newly diagnosed multiple myeloma.

Lancet Oncol. 2010 Oct;11(10):909-10. doi: 10.1016/S1470-2045(10)70199-6. Epub 2010 Aug 23.

7

Lenalidomide in multiple myeloma: current role and future directions.

Expert Opin Pharmacother. 2010 Apr;11(5):829-42. doi: 10.1517/14656561003645611.

8

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.

J Clin Oncol. 2014 Mar 1;32(7):634-40. doi: 10.1200/JCO.2013.52.0023. Epub 2014 Jan 21.

9

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.

Lancet Oncol. 2010 Oct;11(10):934-41. doi: 10.1016/S1470-2045(10)70187-X. Epub 2010 Aug 23.

10

Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

Exp Hematol. 2006 Dec;34(12):1616. doi: 10.1016/j.exphem.2006.07.010.